FEXONAAF 1
FEXONAAF 2
FEXONAAF thumbnail 1
FEXONAAF thumbnail 2

FEXONAAF

Generic: Fexofenadine HClAntihistamine
Product information at a glance
Available strengths
120 mg30 mg
Dosage form
Film-coated tablet, Suspension
Pack sizes
Each box contains 3x10 tablets in Alu-PVC blister strip.Each bottle contains 50 ml suspension.

Strengths, dosage forms and pack sizes are taken from the product composition and packing information below.

Composition

  • Fexonaaf 120 Tablet: Each film-coated tablet contains Fexofenadine Hydrochloride USP 120 mg.
  • Fexonaaf 50 ml Suspension: Each 5 ml suspension contains Fexofenadine Hydrochloride USP 30 mg.

Indications

  • Seasonal Allergic Rhinitis – Symptoms treated effectively include sneezing, rhinorrhea, itchy nose/palate/throat, and itchy/watery/red eyes.
  • Chronic Idiopathic Urticaria – Fexonaaf is indicated for treatment of uncomplicated skin manifestations in adults and children aged 6 months to 11 years. It significantly reduces pruritus and the number of wheals.

Presentation & packing

  • Fexonaaf 120 Tablet: Each box contains 3x10 tablets in Alu-PVC blister strip.
  • Fexonaaf 50 ml Suspension: Each bottle contains 50 ml suspension.

Leaflet & prescribing information

Distributor enquiry

Speak to the NAAFCO Pharma export and distribution team about supply, pack sizes and availability of FEXONAAF.

Related Products

NAAFCO Logo

Wellness through Innovation